These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 36310151)
41. Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection. Sas K; Szabó E; Vécsei L Molecules; 2018 Jan; 23(1):. PubMed ID: 29342113 [TBL] [Abstract][Full Text] [Related]
43. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease. Badawy AA Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of the kynurenine-NAD+ pathway leads to energy failure and exacerbates apoptosis in pneumococcal meningitis. Bellac CL; Coimbra RS; Christen S; Leib SL J Neuropathol Exp Neurol; 2010 Nov; 69(11):1096-104. PubMed ID: 20940631 [TBL] [Abstract][Full Text] [Related]
46. Kynurenine pathway metabolites and enzymes involved in redox reactions. González Esquivel D; Ramírez-Ortega D; Pineda B; Castro N; Ríos C; Pérez de la Cruz V Neuropharmacology; 2017 Jan; 112(Pt B):331-345. PubMed ID: 26970015 [TBL] [Abstract][Full Text] [Related]
47. Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism. Frederick DW; Davis JG; Dávila A; Agarwal B; Michan S; Puchowicz MA; Nakamaru-Ogiso E; Baur JA J Biol Chem; 2015 Jan; 290(3):1546-58. PubMed ID: 25411251 [TBL] [Abstract][Full Text] [Related]
48. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Sas K; Robotka H; Toldi J; Vécsei L J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670 [TBL] [Abstract][Full Text] [Related]
49. Sorbitol dehydrogenase inhibitor protects the liver from ischemia/reperfusion-induced injury via elevated glycolytic flux and enhanced sirtuin 1 activity. Zhang C; Li X; Liu Q Mol Med Rep; 2015 Jan; 11(1):283-8. PubMed ID: 25333577 [TBL] [Abstract][Full Text] [Related]
50. Olprinone protects the liver from ischemia-reperfusion injury through oxidative stress prevention and protein kinase Akt activation. Bejaoui M; Zaouali MA; Sakly R; Ben Abdennebi H Can J Physiol Pharmacol; 2018 Mar; 96(3):227-231. PubMed ID: 28675791 [TBL] [Abstract][Full Text] [Related]
51. Real-time fMRI neurofeedback amygdala training may influence kynurenine pathway metabolism in major depressive disorder. Tsuchiyagaito A; Smith JL; El-Sabbagh N; Zotev V; Misaki M; Al Zoubi O; Kent Teague T; Paulus MP; Bodurka J; Savitz J Neuroimage Clin; 2021; 29():102559. PubMed ID: 33516062 [TBL] [Abstract][Full Text] [Related]
52. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD Grolla AA; Miggiano R; Di Marino D; Bianchi M; Gori A; Orsomando G; Gaudino F; Galli U; Del Grosso E; Mazzola F; Angeletti C; Guarneri M; Torretta S; Calabrò M; Boumya S; Fan X; Colombo G; Travelli C; Rocchio F; Aronica E; Wohlschlegel JA; Deaglio S; Rizzi M; Genazzani AA; Garavaglia S J Biol Chem; 2020 Mar; 295(11):3635-3651. PubMed ID: 31988240 [TBL] [Abstract][Full Text] [Related]
53. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Braidy N; Liu Y Exp Gerontol; 2020 Apr; 132():110831. PubMed ID: 31917996 [TBL] [Abstract][Full Text] [Related]
54. Reduced nicotinamide mononucleotide is a new and potent NAD Zapata-Pérez R; Tammaro A; Schomakers BV; Scantlebery AML; Denis S; Elfrink HL; Giroud-Gerbetant J; Cantó C; López-Leonardo C; McIntyre RL; van Weeghel M; Sánchez-Ferrer Á; Houtkooper RH FASEB J; 2021 Apr; 35(4):e21456. PubMed ID: 33724555 [TBL] [Abstract][Full Text] [Related]
55. Crystal structure of human nicotinic acid phosphoribosyltransferase. Marletta AS; Massarotti A; Orsomando G; Magni G; Rizzi M; Garavaglia S FEBS Open Bio; 2015; 5():419-28. PubMed ID: 26042198 [TBL] [Abstract][Full Text] [Related]
56. Mitochondrial function in liver cells is resistant to perturbations in NAD Dall M; Trammell SAJ; Asping M; Hassing AS; Agerholm M; Vienberg SG; Gillum MP; Larsen S; Treebak JT J Biol Chem; 2019 Sep; 294(36):13304-13326. PubMed ID: 31320478 [TBL] [Abstract][Full Text] [Related]
57. The preferred route of kynurenine metabolism in the rat. Bender DA; McCreanor GM Biochim Biophys Acta; 1982 Jul; 717(1):56-60. PubMed ID: 7104391 [TBL] [Abstract][Full Text] [Related]
58. Hyperthermophilic Archaeon Thermococcus kodakarensis Utilizes a Four-Step Pathway for NAD Hachisuka SI; Sato T; Atomi H J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29555696 [TBL] [Abstract][Full Text] [Related]
59. Differential effects of kynurenine and tryptophan treatment on quinolinate immunoreactivity in rat lymphoid and non-lymphoid organs. Moffett JR; Blinder KL; Venkateshan CN; Namboodiri MA Cell Tissue Res; 1998 Sep; 293(3):525-34. PubMed ID: 9716743 [TBL] [Abstract][Full Text] [Related]
60. HIV and comorbidities - the importance of gut inflammation and the kynurenine pathway. MacCann R; Landay AL; Mallon PWG Curr Opin HIV AIDS; 2023 Mar; 18(2):102-110. PubMed ID: 36722199 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]